MD Anderson Cancer Center 13th Update on the Management of Genitourinary Malignancies Conference

The MD Anderson Cancer Center (MDACC) 13th Update on the Management of Genitourinary Malignancies Conference took place in Houston, Texas at the end of last week (9-10 November). Kidney cancer highlights from the meeting have been published by UroToday. You can read more online on UroToday below:

MDACC 2018: Promising Emerging Systemic Therapies for mRCC

MDACC 2018: Debate: Is There Still a Role for Cytoreductive Nephrectomy in the Setting of Metastatic Renal Cell Carcinoma?

MDACC 2018: Debate: What is the Best Salvage Therapy After Failure of Immune Checkpoint Inhibition?

MDACC 2018: Debate: What is the Best Front-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma?

MDACC 2018: The Evolving Role of Epigenetics in Renal Cell Carcinoma

MDACC 2018: Management of Venous Involvement in Locally Advanced Renal Cell Carcinoma

MDACC 2018: Debate: Adjuvant Therapy for Locally Advanced Renal Cell Carcinoma: Is it Ready for Prime Time?

MDACC 2018: Debate: What is the Role of Biopsy in the Management of the Small Renal Mass?

MDACC 2018: Where Do We Stand with Genetic Screening for Familial Syndromes of RCC and Optimal Management of Patients with VHL?

Share this Post!


Related post

  TOP